Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 424,142 | 33,247 | 5,060 | 23,383 | 52 |
| Depreciation Amortization | -2,316 | -1,896 | -976 | -4,709 | -3,377 |
| Income taxes - deferred | -366,627 | N/A | N/A | N/A | N/A |
| Accounts receivable | -136,199 | -102,331 | -60,936 | -78,092 | -64,634 |
| Other Working Capital | -149,994 | -85,282 | -48,541 | -109,297 | -48,557 |
| Other Operating Activity | 186,562 | 134,983 | 76,678 | 128,198 | 101,640 |
| Operating Cash Flow | $-44,432 | $-21,279 | $-28,715 | $-40,517 | $-14,876 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 30,834 | 128,500 | -11,659 | 384 | -15,425 |
| PPE Investments | -147 | -67 | -25 | -45 | -24 |
| Purchase Of Investment | -1,250 | -145,359 | -1,250 | -1,375 | -1,375 |
| Investing Cash Flow | $29,437 | $-16,926 | $-12,934 | $-1,036 | $-16,824 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 244,815 | 244,815 |
| Debt Repayment | N/A | N/A | N/A | -107,553 | -107,553 |
| Common Stock Issued | 453 | 453 | 21 | 914 | 344 |
| Common Stock Repurchased | -91,240 | -12,998 | -6,123 | -8,760 | -2,149 |
| Other Financing Activity | 0 | 0 | 0 | -889 | -858 |
| Financing Cash Flow | $-90,787 | $-12,545 | $-6,102 | $128,527 | $134,599 |
| Beginning Cash Position | 181,192 | 181,192 | 181,192 | 94,218 | 94,218 |
| End Cash Position | 75,410 | 130,442 | 133,441 | 181,192 | 197,117 |
| Net Cash Flow | $-105,782 | $-50,750 | $-47,751 | $86,974 | $102,899 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,432 | -21,279 | -28,715 | -40,517 | -14,876 |
| Capital Expenditure | -147 | -67 | -25 | -45 | -24 |
| Free Cash Flow | -44,579 | -21,346 | -28,740 | -40,562 | -14,900 |